AmeriSource/Bergen merger
Executive Summary
Cardinal has been contacted by the Federal Trade Commission for information on the drug wholesale market related to the proposed merger of AmeriSource and Bergen Brunswig, CEO Robert Walter says. "We're certainly obligated to respond and will respond with the appropriate information," he says. "We're not taking a public position on this merger," Walter adds. "I don't frankly think the FTC is interested in our opinion about it as a competitor. I think they're interested in knowing more about the market, and we'll participate fully"